---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-016012"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:37:48.129068+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Kimberly J. Tzoumakas resigns from Coherus board effective Dec 31, 2024

## Summary
- Kimberly J. Tzoumakas resigned from Coherus BioSciences Board, effective December 31, 2024.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced as of the filing date.
- The Company thanked Ms. Tzoumakas for her contributions during her tenure.

## SEC filing metadata
- accession: 0001558370-24-016012
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000155837024016012/0001558370-24-016012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024016012/chrs-20241127x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-016012
- JSON: https://secwatch.observer/filing/0001558370-24-016012.json
- Plain text: https://secwatch.observer/filing/0001558370-24-016012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.